(Q48415776)

11 February 2018

title

Selective increase in TNF alpha permeation across the blood-spinal cord barrier after SCI. (English)

1 reference

11 February 2018

0 references

5

Abba J Kastin

1 reference

11 February 2018

author name string

Weihong Pan

1

1 reference

11 February 2018

Lihua Zhang

2

1 reference

11 February 2018

Jie Liao

3

1 reference

11 February 2018

Balazs Csernus

4

1 reference

11 February 2018

publication date

1 January 2003

1 reference

11 February 2018

Journal of Neuroimmunology

published in

1 reference

11 February 2018

volume

134

1 reference

11 February 2018

issue

1-2

1 reference

11 February 2018

page(s)

111-117

1 reference

11 February 2018

Effect of spinal cord injury on the permeability of the blood-brain and blood-spinal cord barriers to the neurotropin PACAP.

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2802%2900426-5

7 January 2021

Systemically administered interleukin-10 reduces tumor necrosis factor-alpha production and significantly improves functional recovery following traumatic spinal cord injury in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2802%2900426-5

7 January 2021

Murine tumor necrosis factor alpha is transported from blood to brain in the mouse.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2802%2900426-5

7 January 2021

Sequential mRNA expression for immediate early genes, cytokines, and neurotrophins in spinal cord injury

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2802%2900426-5

7 January 2021

Elevated serum titers of proinflammatory cytokines and CNS autoantibodies in patients with chronic spinal cord injury

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2802%2900426-5

7 January 2021

Spinal cord compression injury in guinea pigs: structural changes of endothelium and its perivascular cell associations after blood-brain barrier breakdown and repair

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2802%2900426-5

7 January 2021

Vasoactive intestinal peptide and pituitary adenylyl cyclase-activating polypeptide inhibit tumor necrosis factor-alpha production in injured spinal cord and in activated microglia via a cAMP-dependent pathway

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2802%2900426-5

7 January 2021

Tumor necrosis factor receptor deletion reduces nuclear factor-kappaB activation, cellular inhibitor of apoptosis protein 2 expression, and functional recovery after traumatic spinal cord injury

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2802%2900426-5

7 January 2021

Effects of pro-inflammatory cytokines in experimental spinal cord injury.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2802%2900426-5

7 January 2021

Tumour necrosis factor signal transduction

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2802%2900426-5

7 January 2021

Role of tumor necrosis factor-alpha in neuronal and glial apoptosis after spinal cord injury

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2802%2900426-5

7 January 2021

Cytokines modulate the inflammatory response and change permissiveness to neuronal adhesion in injured mammalian central nervous system

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2802%2900426-5

7 January 2021

The blood-spinal cord barrier after injury: pattern of vascular events proximal and distal to a transection in the rat.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2802%2900426-5

7 January 2021

Increase in TNFalpha transport after SCI is specific for time, region, and type of lesion.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2802%2900426-5

7 January 2021

TNFalpha transport across the blood-brain barrier is abolished in receptor knockout mice.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2802%2900426-5

7 January 2021

Blood-brain barrier permeability to ebiratide and TNF in acute spinal cord injury.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2802%2900426-5

7 January 2021

Permeability of the blood-brain and blood-spinal cord barriers to interferons.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2802%2900426-5

7 January 2021

Tumor necrosis factor-alpha: a neuromodulator in the CNS.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2802%2900426-5

7 January 2021

Saturable entry of leukemia inhibitory factor from blood to the central nervous system

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2802%2900426-5

7 January 2021

A quantitative spatial analysis of the blood-spinal cord barrier. I. Permeability changes after experimental spinal contusion injury.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2802%2900426-5

7 January 2021

Differential acute and chronic responses of tumor necrosis factor-deficient mice to experimental brain injury

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2802%2900426-5

7 January 2021

Tumor necrosis factor facilitates regeneration of injured central nervous system axons

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2802%2900426-5

7 January 2021

Breakdown of the blood-brain barrier after fluid percussive brain injury in the rat. Part 1: Distribution and time course of protein extravasation

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2802%2900426-5

7 January 2021

Production of tumor necrosis factor in spinal cord following traumatic injury in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2802%2900426-5

7 January 2021

Methylprednisolone inhibition of TNF-alpha expression and NF-kB activation after spinal cord injury in rats.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2802%2900426-5

7 January 2021

Cellular localization of tumor necrosis factor-alpha following acute spinal cord injury in adult rats

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2802%2900426-5

7 January 2021

10.1016/S0165-5728(02)00426-5

Identifiers

DOI

1 reference

11 February 2018

1 reference

11 February 2018